Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., Feb.…
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today…
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:30 ET | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO,…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:30 ET | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, the…
Replimune Announces Inducement Grants Under NasdaqListing Rule 5635(c)(4)
February 07, 2025 16:01 ET | Source: Replimune Group Inc WOBURN, Mass.,…
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq:…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:01 ET | Source: Chimerix, Inc. DURHAM, N.C., Jan.…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…